[Monoclonal antibodies to the Japanese encephalitis virus in ascitic hybridoma preparations]. 1986

P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova

Among 4 ascitic preparations of hybridomas producing monoclonal antibodies to the Japanese encephalitis virus (JE) hybridomas JE-4 and JE-19 had high multiplication potentials and high levels of reimplantation and transplantability in mice BALB/c. The possibility of using the complete Freund's adjuvant and pristan for priming the mice was shown. The use of pristan promoted a significant decrease in the periods of ascitic tumor development and an increase in accumulation of the cells in the ascitic tumor, in the volume of the ascitic fluid and the titers of the monoclonal antibodies. The serological assays revealed that the monoclonal antibodies produced by JE hybridomas did not react with the JE virus antigen in the hemagglutination inhibition test. However, they were highly active in the indirect immunofluorescence test. IgM of hybridoma JE-19 reacted with the JE virus antigen in the complement fixation test while monoclonal IgG produced by hybridoma JE-4 was active in the neutralization test when titrated in the cultures of the swine embryo kidney transplantable cells. The monoclonal JE antibodies did not react with the JE virus antigen in the hemagglutination inhibition test and did not bind to the antigen of the "Sofin" strain of the forest-spring encephalitis virus in the test performed with the indirect fluorescent antibody technique.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D004664 Encephalitis Virus, Japanese A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent. Japanese B Encephalitis Virus,Japanese Encephalitis Virus,Virus, Japanese Encephalitis
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
August 1986, The Indian journal of medical research,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
October 1982, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
April 2015, Monoclonal antibodies in immunodiagnosis and immunotherapy,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
January 2013, The Journal of veterinary medical science,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
January 1985, Voprosy virusologii,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
August 1983, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
June 1983, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
December 2013, Monoclonal antibodies in immunodiagnosis and immunotherapy,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
December 1992, Acta virologica,
P G Deriabin, and N V Loginova, and G A Lebedeva, and A S Novokhatskiĭ, and I V Malakhova
September 2006, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology,
Copied contents to your clipboard!